Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Chromocell Therapeutics Corporation | CHRO | AMEX | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
2,01 | 1,64 | 2,12 | 2,01 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
15.5.2024 | 22:15 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
15.5.2024 | 22:06 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13.5.2024 | 15:00 | GLOBE | Chromocell To Present at Alliance Global Partner’s.. |
09.4.2024 | 14:30 | GLOBE | Chromocell Issues Letter to Stockholders from Chief.. |
21.3.2024 | 13:30 | GLOBE | Chromocell Announces Formal Launch of Eye Pain Treatment.. |
18.3.2024 | 15:00 | GLOBE | Chromocell Names Frank Knuettel as Chief Executive Officer,.. |
11.3.2024 | 14:00 | GLOBE | Chromocell to Present at Sidoti Virtual Investor Conference.. |
27.2.2024 | 14:00 | GLOBE | Benuvia Operations, LLC and Chromocell Therapeutics Corp... |
21.2.2024 | 22:47 | GLOBE | Chromocell Therapeutics Announces Closing of Initial Public.. |
16.2.2024 | 14:00 | GLOBE | Chromocell Therapeutics Announces Pricing of Upsized $6.6.. |